Corbus Pharmaceuticals Holdings (CRBP) Financials
CRBP Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 28.3 million | 35.2 million |
2023-09-30 | 36.3 million | 36.0 million |
2023-06-30 | 43.7 million | 34.2 million |
2023-03-31 | 51.6 million | 35.2 million |
CRBP Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -6.0 million | 799177 |
2023-09-30 | -7.2 million | 821223 |
2023-06-30 | -7.8 million | 823375 |
2023-03-31 | -15.1 million | 1.0 million |
CRBP Net Income
No data available :(
CRBP Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 21.1 million | - | 4.7 million |
2023-09-30 | 28.7 million | - | 5.0 million |
2023-06-30 | 36.6 million | 11.3 million | 5.3 million |
2023-03-31 | 44.2 million | 14.0 million | 5.7 million |
CRBP Shares Outstanding
CRBP Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | - | 7.0 million | 3.1 million | 147978 |
2023-09-30 | - | 6.6 million | 2.9 million | - |
2023-06-30 | - | 4.2 million | 3.9 million | - |
2023-03-31 | - | 13.4 million | 3.9 million | - |
CRBP Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | - | 147978 |
2023-09-30 | - | 152809 |
2023-06-30 | - | 158343 |
2023-03-31 | - | 363740 |
CRBP
Price: $38.77
52 week price:
Earnings Per Share: -10.31 USD
P/E Ratio: -2.35
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 1.8 million
Ebitda: -6.8 millionMarket Capitalization: 419.4 million